Abbott reports sales of $10.6bn for Q3 2024
Abbott Laboratories has reported sales of $10.6bn for the third quarter (Q3) of 2024, as against $10.4bn in Q2 2024,…
All articles by Tiash saha
Tiash saha
-
-
UCL and UCLH develop AI-based tool for brain tumour scan analysis
Researchers at University College London (UCL) and University College London Hospitals (UCLH) in the UK have developed an AI-based tool…
-
ONWARD Medical licenses WIMAGINE BCI for spinal cord injury treatment
ONWARD Medical has acquired an exclusive licence from CEA for the development and commercialisation of the WIMAGINE Brain-Computer Interface (BCI)…
-
GE HealthCare to launch Theranostics centre for cancer care in Germany
GE HealthCare has collaborated with University Medicine Essen (UME) to establish a new Theranostics Centre of Excellence in Germany to…
-
Aspira Women’s Health gets approval for OvaWatch ovarian cancer test
Aspira Women's Health has received approval from the New York State Department of Health's (NYDOH) Clinical Laboratory Evaluation Program (CLEP)…
-
Gilardoni partners with Precision X-Ray for RADGIL2 distribution in US
Gilardoni has entered into an exclusive distribution partnership with Precision X-Ray for the RADGIL2 X-ray blood irradiator in the US.…
-
Hologic to acquire Gynesonics to strengthen women’s health portfolio
Hologic has signed a definitive agreement for the acquisition of Gynesonics, which develops minimally invasive solutions for women’s health, in…
-
BD launches automated, robotics-compatible reagent kits
Becton, Dickinson and Company (BD) has announced the commercial launch of automation-ready, robotics-compatible reagent kits designed for single-cell discovery studies.…
-
ICR researchers study saliva-based test for prostate cancer
Researchers at the Institute of Cancer Research in London have launched a study to evaluate a new saliva-based test, PRODICT,…
-
FDA approves Medtronic’s Affera system for VT treatment study
Medtronic has announced US Food and Drug Administration (FDA) approval to conduct an early feasibility study using the Affera Mapping…